1. Home
  2. APWC vs ENTX Comparison

APWC vs ENTX Comparison

Compare APWC & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APWC

Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)

HOLD

Current Price

$1.58

Market Cap

61.4M

Sector

Industrials

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$2.05

Market Cap

58.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APWC
ENTX
Founded
1996
2010
Country
Taiwan
Israel
Employees
1175
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.4M
58.2M
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
APWC
ENTX
Price
$1.58
$2.05
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
26.8K
259.3K
Earning Date
04-29-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
N/A
$42,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.60
$30.43
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$0.91
52 Week High
$2.34
$3.22

Technical Indicators

Market Signals
Indicator
APWC
ENTX
Relative Strength Index (RSI) 48.49 71.50
Support Level $1.30 $1.48
Resistance Level $1.64 $2.27
Average True Range (ATR) 0.08 0.14
MACD -0.01 0.02
Stochastic Oscillator 45.83 83.80

Price Performance

Historical Comparison
APWC
ENTX

About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)

Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in the manufacture and distribution of enameled wire, power cable, and telecommunications products in Thailand, Singapore, Australia, the PRC, Hong Kong, and certain other markets in the Asia Pacific region. It also provides project engineering services in the supply, delivery, and installation of power cables (SDI). Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and the rest of the World.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: